Tuesday, June 21, 2011

Analysts Actions: RIMM, SPWRA, MMI, BIIB, WEN

Research in Motion Limited (NASDAQ: RIMM): Credit Suisse downgraded iots rating on the company to Neutral from Outperform.

SunPower Corporation (NASDAQ: SPWRA): Wunderlich Securities upgraded its rating on the company to Hold from Sell. The firm left its price target unchanged at $16.

Motorola Mobility Holdings (NYSE: MMI): Credit Suisse lowered its rating on the company to Underperform  from Outperform.

Biogen Idec (NASDAQ: BIIB): Deutsche Bank raised its rating on the company to Buy from Hold. In a note to clients, the firm stated, "1) Our analysis suggests CONFIRM will show BG-12 is more effective than Copaxone & DEFINE data will remain strong. Combo BG-12 & daclizumab Q3 data are under-appreciated. 2) We believe Tysabri will reach a positive inflection by YE:11 with most pts on drug being JCV negative in US. 3) Our due diligence suggests a greater likelihood of success for hemophilia trials in '12."

Wendy's-Arby's Group (NYSE: WEN): Argus upgraded the stock to Hold from Sell.

Full Disclosure: None.
Related Posts with Thumbnails

Wikinvest Wire